Metabolomic prediction of fetal congenital heart defect in the first trimester.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  American Journal of Obstetrics and Gynecology

• Publication date

  2014-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.ogx.0000460703.82095.3bPMID 24704061
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolomic analysis for first-trimester Down syndrome prediction.

  2013cited by this paper
• Performance of Different Scan Protocols of Fetal Echocardiography in the Diagnosis of Fetal Congenital Heart Disease: A Systematic Review and Meta-Analysis

  2013cited by this paper
• Meta Analysis of the Association between MTHFR C677T Polymorphism and the Risk of Congenital Heart Defects

  2012cited by this paper
• Fetal cardiac screening and variation in prenatal detection rates of congenital heart disease: why bother with screening at all?

  2012cited by this paper
• Metabolomics and first-trimester prediction of early-onset preeclampsia

  2012cited by this paper
• MetaboAnalyst 2.0—a comprehensive server for metabolomic data analysis

  2012cited by this paper
• Translational biomarker discovery in clinical metabolomics: an introductory tutorial

  2012cited by this paper
• Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression

  2012cited by this paper
• Barriers to prenatal detection of congenital heart disease: a population‐based study

  2012cited by this paper
• Annual Summary of Vital Statistics: 2009

  2012cited by this paper
• Advances in metabolite identification.

  2011cited by this paper
• Costs of prenatal detection of congenital heart disease.

  2011cited by this paper
• Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression.

  2011cited by this paper
• Uncovering the metabolomic fingerprint of breast cancer.

  2011cited by this paper
• The Human Serum Metabolome

  2011cited by this paper
• Computational approaches to metabolomics.

  2010cited by this paper
• Current status of fetal cardiac intervention.

  2010cited by this paper
• Nuchal translucency and the risk of congenital heart disease.

  2007cited by this paper
• ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities.

  2007cited by this paper
• Population‐based study of antenatal detection of congenital heart disease by ultrasound examination

  2007cited by this paper
• Hospital stays, hospital charges, and in-hospital deaths among infants with selected birth defects--United States, 2003.

  2007cited by this paper
• Twenty-year trends in diagnosis of life-threatening neonatal cardiovascular malformations

  2007cited by this paper
• Disorders of carnitine transport and the carnitine cycle

  2006cited by this paper
• Trends in Prenatal Diagnosis, Pregnancy Termination, and Perinatal Mortality of Newborns With Congenital Heart Disease in France, 1983–2000: A Population-Based Evaluation

  2005cited by this paper
• Accuracy of fetal echocardiography in the routine detection of congenital heart disease among unselected and low risk populations: a systematic review

  2005cited by this paper
• Elevated first-trimester nuchal translucency increases the risk of congenital heart defects.

  2005cited by this paper
• Congenital heart defects and maternal biomarkers of oxidative stress.

  2005cited by this paper
• Congenital heart defects and abnormal maternal biomarkers of methionine and homocysteine metabolism.

  2005cited by this paper
• Delivery room and early postnatal management of neonates who have prenatally diagnosed congenital heart disease.

  2005cited by this paper
• Prenatal Diagnosis of the Fetus with Hypoplastic Left Heart Syndrome

  2003cited by this paper
• The incidence of congenital heart disease.

  2002cited by this paper
• Report of the task force on children and youth. American Heart Association.

  1993cited by this paper
• Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle.

  1974cited by this paper

• Dietary Sources of Glycine Betaine and Proline Betaine in Plant Foods and Their Potential Biological Relevance in Human Nutrition.

  2026cites this paper
• Decoding adipose–brain crosstalk: Distinct lipid cargo in human adipose‐derived extracellular vesicles modulates amyloid aggregation in Alzheimer's disease

  2025cites this paper
• Prenatal Metabolomics Analysis and Fetal Congenital Anomalies and Genetic Conditions: A Review of Current Literature

  2025cites this paper
• Metabolomic characteristics of cord blood from neonates with hyperkalemia after antenatal exposure to ritodrine and magnesium sulfate

  2025cites this paper
• Adverse events during pregnancy, circulating metabolites, and congenital malformations: a Mendelian randomization study

  2025cites this paper
• Identification of serum N,N-dimethylglycine as a potential biomarker for prenatal diagnosis of congenital heart disease using 1HNMR and UPLC-MS/MS metabonomics

  2025cites this paper
• Metabolomics and pediatric cardiology.

  2025cites this paper
• Integrative metabolomics dictate distinctive signature profiles in patients with Tetralogy of Fallot

  2024cites this paper
• Metabolomic profiles of infants classified as sudden infant death syndrome: a case-control analysis

  2024cites this paper
• Metabolomic profiling of infants undergoing cardiopulmonary bypass and association with clinical outcomes: a systematic review

  2024cites this paper
• Biomarkers for congenital ventricular outflow tract malformations based on maternal serum lipid metabolomics analysis

  2024cites this paper
• Serum Raman spectroscopy: Unearthing the snapshot of distinct metabolic profile in patients with congenital heart defects (CHDs)

  2024cites this paper
• Plasma metabolomic and lipidomic profiles accurately classify mothers of children with congenital heart disease: an observational study

  2024cites this paper
• The combination of deep learning and pseudo-MS image improves the applicability of metabolomics to congenital heart defect prenatal screening.

  2024cites this paper
• Exploring the adverse effects of 1,3,6,8-tetrabromo-9H-carbazole in atherosclerotic model mice by metabolomic profiling integrated with mechanism studies in vitro.

  2023cites this paper
• A Systematic Review on Metabolomics Analysis in Hearing Impairment: Is It a Possible Tool in Understanding Auditory Pathologies?

  2023cites this paper
• A Metabolic Biomarker Panel for Congenital Heart Disease Assessment with Newborn Dried Blood Spots

  2023cites this paper
• Pregnancy in Patients with Moderate and Highly Complex Congenital Heart Disease

  2023cites this paper
• Metabolomic Profiling in Mouse Model of Menopause-Associated Asthma

  2023cites this paper
• The value of lipid metabolites 9,10-DOA and 11,12-EET in prenatal diagnosis of fetal heart defects.

  2023cites this paper
• Combined Omics Analysis Further Unveils the Specific Role of Butyrate in Promoting Growth in Early-Weaning Animals

  2023cites this paper
• Maternal metabolomic profiling and congenital heart disease risk in offspring: A systematic review of observational studies

  2023cites this paper
• Metabolomics Signatures and Subsequent Maternal Health among Mothers with a Congenital Heart Defect-Affected Pregnancy

  2022cites this paper
• Combining MALDI-MS with machine learning for metabolomic characterization of lung cancer patient sera.

  2022cites this paper
• A metabolomic-based biomarker discovery study for predicting phototherapy duration for neonatal hyperbilirubinemia

  2022cites this paper
• Metabolomics: A New Tool in Our Understanding of Congenital Heart Disease

  2022cites this paper
• Biomarkers for isolated congenital heart disease based on maternal amniotic fluid metabolomics analysis

  2022cites this paper
• A screening test proposal for congenital defects based on maternal serum metabolomics profile.

  2022cites this paper
• Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials

  2022influential citation
• The Relationship of Maternal Gestational Mass Spectrometry-Derived Metabolites with Offspring Congenital Heart Disease: Results from Multivariable and Mendelian Randomization Analyses

  2022cites this paper
• Analysis of Biomarkers for Congenital Heart Disease Based on Maternal Amniotic Fluid Metabolomics

  2021cites this paper
• Noninvasive screening for congenital heart defects using a serum metabolomics approach

  2021cites this paper
• Association of maternal gut microbiota and plasma metabolism with congenital heart disease in offspring: a multi-omic analysis

  2021cites this paper
• Urine metabolomic biomarkers for prediction of isolated fetal congenital heart defect

  2021cites this paper
• Metabolomics in Prenatal Medicine: A Review

  2021cites this paper
• Severity-Dependent Profile of the Metabolome in Hypospadias

  2020cites this paper
• Development and application of an LC-MS/MS method for determining methylsulfonylmethane (MSM) levels in human plasma

  2020cites this paper
• Metabolomics in genetic testing.

  2020cites this paper
• Metabolic Dynamics and Prediction of Gestational Age and Time to Delivery in Pregnant Women

  2020cites this paper
• Metabolomic identification of placental alterations in fetal growth restriction

  2020cites this paper
• Pre-surgery urine metabolomics may predict late neurodevelopmental outcome in children with congenital heart disease

  2019cites this paper
• Metabolic Biomarkers In Midtrimester Maternal Plasma Can Accurately Predict Adverse Pregnancy Outcome in Patients with SLE

  2019cites this paper
• Study on the Potential Biomarkers of Maternal Urine Metabolomics for Fetus with Congenital Heart Diseases Based on Modified Gas Chromatograph-Mass Spectrometer

  2019cites this paper
• Hypoplastic left heart syndrome: From bedside to bench and back.

  2019cites this paper
• Metabolomic profiling revels systemic signatures of premature aging induced by Hutchinson-Gilford Progeria Syndrome

  2019cites this paper
• Microbial and metabolomic remodeling by a formula of Sichuan dark tea improves hyperlipidemia in apoE-deficient mice

  2019cites this paper
• Metabolomic profiling suggests systemic signatures of premature aging induced by Hutchinson–Gilford progeria syndrome

  2019cites this paper
• Artificial intelligence and amniotic fluid multiomics: prediction of perinatal outcome in asymptomatic women with short cervix

  2019cites this paper
• Untargeted metabolomics: an overview of its usefulness and future potential in prenatal diagnosis

  2018cites this paper
• Potential role of "omics" technique in prenatal diagnosis of congenital heart defects.

  2018cites this paper
• Pregestational type 2 diabetes mellitus induces cardiac hypertrophy in the murine embryo through cardiac remodeling and fibrosis

  2017cites this paper
• Predicting congenital heart defects: A comparison of three data mining methods

  2017cites this paper
• Dyslipidemia in pregnancy may contribute to increased risk of congenital heart defects

  2017cites this paper
• Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized Medicine

  2017cites this paper
• A metabolomics-based approach for non-invasive diagnosis of chromosomal anomalies

  2017cites this paper
• Metabolomic determination of pathogenesis of late-onset preeclampsia

  2017cites this paper
• Technologies to study genetics and molecular pathways

  2016cites this paper
• Carbohydrate and fatty acid perturbations in the amniotic fluid of the recipient twin of pregnancies complicated by twin-twin transfusion syndrome in relation to treatment and fetal cardiovascular risk.

  2016cites this paper
• Serum metabolomic markers for traumatic brain injury: a mouse model

  2016influential citation
• Curcumin ameliorates high glucose-induced neural tube defects by suppressing cellular stress and apoptosis.

  2015cites this paper
• Epigenetic markers for newborn congenital heart defect (CHD)

  2015cites this paper
• Oxidative stress is responsible for maternal diabetes-impaired transforming growth factor beta signaling in the developing mouse heart.

  2015cites this paper
• Advances in revealing the molecular targets downstream of oxidative stress-induced proapoptotic kinase signaling in diabetic embryopathy.

  2015cites this paper
• Characterization of Visceral and Subcutaneous Adipose Tissue Transcriptome and Biological Pathways in Pregnant and Non-Pregnant Women: Evidence for Pregnancy-Related Regional-Specific Differences in Adipose Tissue

  2015cites this paper
• Impact of fetal chromosomal disorders on maternal blood metabolome: toward new biomarkers?

  2015cites this paper
• Screening for pregnancy complications at 11-13 weeks’ gestation

  2015cites this paper
• Metabolomics Analysis in Hearing Impairment

  year unknowncites this paper